文献速递重症综合管理与镇静镇痛消化、代谢与肾脏急症

预测性富集预测脓毒症相关急性肾损伤的肾脏替代治疗需求:呋塞米负荷试验联合尿生物标志物TIMP-2与IGFBP-7

Predictive enrichment for the need of renal replacement in sepsis-associated acute kidney injury: combination of furosemide stress test and urinary biomarkers TIMP-2 and IGFBP-7.
PubMed 文献 · Ann Intensive Care · 2024-07-13
一句话结论脓毒症相关AKI患者中,先行呋塞米负荷试验、2小时后测尿TIMP-2*IGFBP-7的两步法可高特异度识别7天内需RRT者,作者认为后续干预试验应验证该高危亚组能否从早期RRT获益。

该前瞻性多中心研究纳入100例脓毒症(诊断<48h)、AKI≥2期且有负液体平衡指征的患者,全部接受标准化呋塞米负荷试验(FST),并在FST前及FST后连续12h内系列检测尿TIMP-2*IGFBP-7,主要终点为纳入后7天内RRT需求。32%(n=32/99)的患者最终需要RRT。单用FST前TIMP-2*IGFBP-7(准确度0.66;95%CI 0.55-0.78)或单用FST(准确度0.74;95%CI 0.64-0.82)预测RRT的准确度中等;以FST为上游筛查、2h后测TIMP-2*IGFBP-7的两步法准确度提高至0.83(95%CI 0.74-0.90,p=0.03),阳性预测值0.86(95%CI 0.64-0.97),特异度0.96(95%CI 0.88-0.99)。作者认为该联合应用支持高特异度识别需RRT的SA-AKI患者,后续干预试验应阐明该高危亚组是否从早期RRT启动中获益。

要点

  • 脓毒症(诊断<48h)、AKI≥2期且有负液体平衡指征者中,7天内32%(32/99)需要RRT。
  • 单用FST前尿TIMP-2*IGFBP-7预测RRT准确度0.66(95%CI 0.55-0.78),单用FST为0.74(95%CI 0.64-0.82)。
  • FST为上游筛查、2h后测TIMP-2*IGFBP-7的两步法准确度0.83(95%CI 0.74-0.90,p=0.03),阳性预测值0.86(95%CI 0.64-0.97),特异度0.96(95%CI 0.88-0.99)。
  • 非RRT患者尿TIMP-2*IGFBP-7在FST后12h内保持低水平,RRT患者在6h后出现反弹。
  • 作者认为该预测性富集方法识别的高危SA-AKI亚组是否从早期RRT启动获益,需后续干预试验阐明。

适用人群与场景

  • 脓毒症诊断<48h、AKI≥2期且有负液体平衡指征的患者,纳入于2020年2月至2022年12月。

处置流程与药物剂量

  • 所有患者接受标准化呋塞米负荷试验(FST)。
  • 在FST前及FST后连续12h内系列检测尿TIMP-2*IGFBP-7。
  • 两步法:以FST为上游筛查工具,FST后2h定量尿TIMP-2*IGFBP-7。

研究设计与关键结果

  • 前瞻性多中心研究,纳入100例脓毒症(诊断<48h)、AKI≥2期且有负液体平衡指征的患者,主要终点为纳入后7天内RRT需求。
  • 32%(n=32/99)的SA-AKI患者在7天内最终需要RRT。
  • FST后2h内尿TIMP-2*IGFBP-7在RRT患者从3.26 ng2/mL2/1000(IQR 1.38-5.53)降至2.36 ng2/mL2/1000(IQR 1.61-4.87),在非RRT患者从1.68 ng2/mL2/1000(IQR 0.56-2.94)降至0.27 ng2/mL2/1000(IQR 0.12-0.89)。
  • 非RRT患者尿TIMP-2*IGFBP-7至12h保持低水平,RRT患者在6h后出现反弹。
  • FST前TIMP-2*IGFBP-7预测RRT需求的准确度为0.66(95%CI 0.55-0.78),FST本身为0.74(95%CI 0.64-0.82)。
  • 以FST为上游筛查、2h后测TIMP-2*IGFBP-7的两步法预测准确度0.83(95%CI 0.74-0.90,p=0.03),优于单用FST,阳性预测值0.86(95%CI 0.64-0.97),特异度0.96(95%CI 0.88-0.99)。

证据类型、等级与局限

  • 证据类型:前瞻性多中心研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,联合应用上游FST后测尿TIMP-2*IGFBP-7支持高特异度识别需要RRT的SA-AKI患者。
  • 作者认为,后续干预试验应阐明由该预测性富集方法识别的高危SA-AKI亚组是否从早期RRT启动中获益。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: In sepsis, initial resuscitation with fluids is followed by efforts to achieve a negative fluid balance. However, patients with sepsis-associated acute kidney injury (SA-AKI) often need diuretic or renal replacement therapy (RRT). The dilemma is to predict whether early RRT might be advantageous or diuretics will suffice. Both the Furosemide Stress Test (FST) and measurements of the urinary biomarkers TIMP-2*IGFBP-7, if applied solely, do not provide sufficient guidance. We tested the hypothesis that a combination of two tests, i.e., an upstream FST combined with downstream measurements of urinary TIMP-2*IGFBP-7 concentrations improves the accuracy in predicting RRT necessity.

METHODS: In this prospective, multicenter study 100 patients with sepsis (diagnosed < 48h), AKI stage ≥ 2, and an indication for negative fluid balance were included between 02/2020 and 12/2022. All patients received a standardized FST and urinary biomarkers TIMP-2*IGFBP-7 were serially measured immediately before and up to 12 h after the FST. The primary outcome was the RRT requirement within 7 days after inclusion.

RESULTS: 32% (n = 32/99) of SA-AKI patients eventually required RRT within 7 days. With the FST, urine TIMP-2*IGFBP-7 decreased within 2 h from 3.26 ng2/mL2/1000 (IQR: 1.38-5.53) to 2.36 ng2/mL2/1000 (IQR: 1.61-4.87) in RRT and 1.68 ng2/mL2/1000 (IQR: 0.56-2.94) to 0.27 ng2/mL2/1000 (IQR: 0.12-0.89) and non-RRT patients, respectively. While TIMP-2*IGFBP-7 concentrations remained low for up to 12 h in non-RRT patients, we noted a rebound in RRT patients after 6 h. TIMP-2*IGFBP-7 before FST (accuracy 0.66; 95%-CI 0.55-0.78) and the FST itself (accuracy 0.74; 95%-CI: 0.64-0.82) yielded moderate test accuracies in predicting RRT requirement. In contrast, a two-step approach, utilizing FST as an upstream screening tool followed by TIMP-2*IGFBP-7 quantification after 2 h improved predictive accuracy (0.83; 95%-CI 0.74-0.90, p = 0.03) compared to the FST alone, resulting in a positive predictive value of 0.86 (95%-CI 0.64-0.97), and a specificity of 0.96 (95%-CI 0.88-0.99).

CONCLUSIONS: The combined application of an upstream FST followed by urinary TIMP-2*IGFBP-7 measurements supports highly specific identification of SA-AKI patients requiring RRT. Upcoming interventional trials should elucidate if this high-risk SA-AKI subgroup, identified by our predictive enrichment approach, benefits from an early RRT initiation.

来源:Ann Intensive Care,查看原文。版权归原作者所有。

参考来源

  1. Palmowski L, Lindau S, Henk LC, et al. Predictive enrichment for the need of renal replacement in sepsis-associated acute kidney injury: combination of furosemide stress test and urinary biomarkers TIMP-2 and IGFBP-7. Ann Intensive Care. 2024. PMID: 39002065. doi:10.1186/s13613-024-01349-4

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。